Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastoma

Oncogene

Volumn 25, Issue 36, 2006, Pages 5046-5055

  Niizuma, H ^a,b   Nakamura, Y ^a   Ozaki, T ^a   Nakanishi, H ^a   Ohira, M ^a   Isogai, E ^a   Kageyama, H ^a   Imaizumi, M ^c   Nakagawara, A ^a  

^a CHIBA CANCER CENTER   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MIYAGI CHILDREN S HOSPITAL   (Japan)

Author keywords

Apoptosis; Bcl 2; Neuroblastoma; Retinoic acid

Indexed keywords

COMPLEMENTARY DNA; PROTEIN BCL 2; PROTEIN BCL XL; RETINOIC ACID; RNA;

APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA CONTENT; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NEUROBLASTOMA; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE, TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRETINOIN;

EID: 33747359664     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209515     Document Type: Article

References (46)

1. Abel F, Sjoberg RM, Nilsson S, Kogner P, Martinsson T. (2005). Eur J Cancer 41: 635-646.
2. Antonsson B. (2001). Cell Tissue Res 306: 347-361.
3. Balmer JE, Blomhoff R. (2002). J Lipid Res 43: 1773-1808.
4. Brodeur GM. (2003). Nat Rev Cancer 3: 203-216.
5. Brodeur GM, Nakagawara A. (1992). Am J Pediatr Hematol Oncol 14: 111-116.
6. Cory S, Huang DC, Adams JM. (2003). Oncogene 22: 8590-8607.
7. Culmsee C, Mattson MP. (2005). Biochem Biophys Res Commun 331: 761-777.
8. Degterev A, Boyce M, Yuan J. (2003). Oncogene 22: 8543-8567.
9. Dole M, Nunez G, Merchant AK, Maybaum J, Rode CK, Bloch CA et al. (1994). Cancer Res 54: 3253-3259.
10. Encinas M, Iglesias M, Llecha N, Comella JX. (1999). J Neurochem 73: 1409-1421.
11. Freemantle SJ, Spinella MJ, Dmitrovsky E. (2003). Oncogene 22: 7305-7315.
12. Gallo G, Giarnieri E, Bosco S, Cappelli C, Alderisio M, Giovagnoli MR et al. (2003). Anticancer Res 23: 777-784.
13. Kim R, Emi M, Tanabe K, Toge T. (2004). Cancer 101: 2491-2502.
14. Lee MH, Nikolic M, Baptista CA, Lai E, Tsai LH, Massague J. (1996). Proc Natl Acad Sci USA 93: 3259-3263.
15. Lippman SM, Lotan R. (2000). J Nutr 130: 479S-482S.
16. Lombet A, Zujovic V, Kandouz M, Billardon C, Carvajal-Gonzalez S, Gompel A et al. (2001). Eur J Biochem 268: 1352-1362.
17. Lopez-Carballo G, Moreno L, Masia S, Perez P, Barettino D. (2002). J Biol Chem 277: 25297-25304.
18. Maden M. (2001). Int Rev Cytol 209: 1-77.
19. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK et al. (1999). N Engl J Med 341: 1165-1173.
20. McCaffery PJ, Adams J, Maden M, Rosa-Molinar E. (2003). Eur J Neurosci 18: 457-472.
21. Melino G, Thiele CJ, Knight RA, Piacentini M. (1997). J Neurooncol 31: 65-83.
22. Morishima N, Nakanishi K, Takenouchi H, Shibata T, Yasuhiko Y. (2002). J Biol Chem 277: 34287-34294.
23. Nagai J, Yazawa T, Okudela K, Kigasawa H, Kitamura H, Osaka H. (2004). Cancer Res 64: 7910-7917.
24. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA et al. (2000). Nature 403: 98-103.
25. Nakagawara A. (1998). Hum Cell 11: 115-124.
26. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM. (1993). N Engl J Med 328: 847-854.
27. Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM. (1994). Mol Cell Biol 14: 759-767.
28. Nakagawara A, Nakamura Y, Ikeda H, Hiwasa T, Kuida K, Su MS et al. (1997). Cancer Res 57: 4578-4584.
29. Nakamura Y, Ozaki T, Koseki H, Nakagawara A, Sakiyama S. (2003). Biochem Biophys Res Commun 307: 206-213.
30. Nikolaev AY, Li M, Puskas N, Qin J, Gu W. (2003). Cell 112: 29-40.
31. Okuno S, Saito A, Hayashi T, Chan PH. (2004). J Neurosci 24: 7879-7887.
32. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA et al. (2005). Nature 435: 677-681.
33. Ostermeyer AG, Runko E, Winkfield B, Ahn B, Moll UM. (1996). Proc Natl Acad Sci USA 93: 15190-15194.
34. Piacentini M, Annicchiarico-Petruzzelli M, Oliverio S, Piredda L, Biedler JL, Melino G. (1992). Int J Cancer 52: 271-278.
35. Puthalakath H, Villunger A, O'Reilly LA, Beaumont JG, Coultas L, Cheney RE et al. (2001). Science 293: 1829-1832.
36. Reynolds CP, Lemons RS. (2001). Hematol Oncol Clin N Am 15: 867-910.
37. Romani P, Lu QL. (1994). J Pathol 172: 273-278.
38. Schor NF. (1999). J Neurooncol 41: 159-166.
39. Shi L, Gong S, Yuan Z, Ma C, Liu Y, Wang C et al. (2004). Neurosci Lett 375: 7-12.
40. Takada N, Isogai E, Kawamoto T, Nakanishi H, Todo S, Nakagawara A. (2001). Med Pediatr Oncol 36: 122-126.
41. Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA et al. (2000). Nat Med 6: 529-535.
42. Thiele CJ, Reynolds CP, Israel MA. (1985). Nature 313: 404-406.
43. Van Noesel MM, Van Bezouw S, Voute PA, Herman JG, Pieters R, Versteeg R. (2003). Genes Chromosomes Cancer 38: 226-233.
44. Van Noesel MM, Versteeg R. (2004). Gene 325: 1-15.
45. Villablanca JG, Khan AA, Avramis VI, Seeger RC, Matthay KK, Ramsay NK et al. (1995). J Clin Oncol 13: 894-901.
46. Wang JL, Liu D, Zhang ZJ, Shan S, Han X, Srinivasula SM et al. (2000). Proc Natl Acad Sci USA 97: 7124-7129.